Jump to:
Chris Shorey joined Ropes & Gray in 2021 as an associate in the corporate department. His practice focuses on transactional matters, representing clients in mergers & acquisitions, capital markets transactions and other strategic transactions. He also advises clients on securities law reporting and compliance obligations and corporate governance matters.
Experience
- Represented KARL STORZ in its acquisition of Asensus Surgical, Inc.
- Represented Paratek Pharmaceuticals, Inc. in its sale to Gurnet Point Capital and Novo Holdings.
- Represented Adaptimmune Therapeutics plc in its strategic combination with TCR2 Therapeutics Inc.
- Represented Provention Bio in its $2.9 billion sale to Sanofi.
- Represented America’s Test Kitchen in its sale to Marquee Brands.
- Represented Martignetti Companies on its acquisition of privately held Hartley & Parker, a Connecticut family-owned liquor distribution company.
- Represented Signify Health in its sale to CVS Health in an all-cash transaction valued at approximately $8 billion in total consideration.
- Represented Pfizer Inc. in its $6.7 billion acquisition of Arena Pharmaceuticals, Inc.